X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (240880) 240880
Book Review (54435) 54435
Publication (15973) 15973
Newsletter (6409) 6409
Newspaper Article (1346) 1346
Conference Proceeding (1137) 1137
Magazine Article (645) 645
Book Chapter (642) 642
Book / eBook (617) 617
Transcript (251) 251
Web Resource (161) 161
Dissertation (98) 98
Trade Publication Article (61) 61
Streaming Video (29) 29
Paper (21) 21
Journal / eJournal (18) 18
Reference (15) 15
Data Set (14) 14
Presentation (10) 10
Government Document (5) 5
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (221865) 221865
humans (216090) 216090
antineoplastic agents - therapeutic use (106354) 106354
female (104028) 104028
oncology (88454) 88454
male (83000) 83000
cancer (70403) 70403
middle aged (66204) 66204
animals (59382) 59382
aged (56076) 56076
adult (52542) 52542
chemotherapy (51483) 51483
antineoplastic combined chemotherapy protocols - therapeutic use (43322) 43322
antineoplastic agents - pharmacology (39240) 39240
treatment outcome (38615) 38615
antineoplastic agents (32826) 32826
care and treatment (31653) 31653
pharmacology & pharmacy (30746) 30746
mice (30585) 30585
cell line, tumor (28785) 28785
antimitotic agents (28127) 28127
neoplasms - drug therapy (27054) 27054
antineoplastic agents - adverse effects (25024) 25024
antineoplastic agents - administration & dosage (22893) 22893
research (22339) 22339
apoptosis (21626) 21626
prognosis (20778) 20778
breast neoplasms - drug therapy (20668) 20668
therapy (20549) 20549
analysis (19109) 19109
aged, 80 and over (18938) 18938
combined modality therapy (18715) 18715
health aspects (17937) 17937
tumors (17893) 17893
hematology (17711) 17711
medicine & public health (16693) 16693
lung neoplasms - drug therapy (15548) 15548
breast cancer (15472) 15472
drug therapy (15189) 15189
apoptosis - drug effects (15148) 15148
retrospective studies (14783) 14783
neoplasm staging (14565) 14565
abridged index medicus (14059) 14059
dose-response relationship, drug (13848) 13848
survival (13761) 13761
expression (13289) 13289
metastasis (13209) 13209
disease-free survival (13102) 13102
cell proliferation - drug effects (12596) 12596
antineoplastic combined chemotherapy protocols - adverse effects (12441) 12441
clinical trials as topic (12265) 12265
adolescent (12162) 12162
antineoplastic agents - chemistry (12108) 12108
carcinoma (12044) 12044
cisplatin (11933) 11933
survival rate (11686) 11686
time factors (11333) 11333
hematology, oncology and palliative medicine (11224) 11224
survival analysis (11191) 11191
surgery (10882) 10882
biochemistry & molecular biology (10750) 10750
article (10704) 10704
radiotherapy (10359) 10359
antineoplastic agents, hormonal - therapeutic use (10268) 10268
follow-up studies (10198) 10198
breast neoplasms - pathology (10125) 10125
cells (9962) 9962
drug resistance, neoplasm (9862) 9862
cell survival - drug effects (9756) 9756
child (9733) 9733
chemotherapy, adjuvant (9722) 9722
in-vitro (9561) 9561
trial (9306) 9306
risk factors (9230) 9230
drug administration schedule (9084) 9084
neoplasm metastasis (9028) 9028
mice, nude (9026) 9026
cancer therapies (9002) 9002
breast-cancer (8970) 8970
drugs (8901) 8901
carcinoma, non-small-cell lung - drug therapy (8881) 8881
clinical trials (8745) 8745
antibodies, monoclonal - therapeutic use (8723) 8723
chemistry, medicinal (8411) 8411
rats (8349) 8349
cisplatin - administration & dosage (8189) 8189
toxicity (8074) 8074
antineoplastic agents, phytogenic - therapeutic use (8024) 8024
oncology, experimental (7980) 7980
proteins (7974) 7974
paclitaxel (7932) 7932
mutation (7586) 7586
xenograft model antitumor assays (7582) 7582
tumor cells, cultured (7570) 7570
signal transduction - drug effects (7482) 7482
cell biology (7444) 7444
doxorubicin (7370) 7370
cytotoxicity (7356) 7356
disease progression (7302) 7302
drug therapy, combination (7273) 7273
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (314) 314
Online Resources - Online (166) 166
Collection Dvlpm't (Acquisitions) - Vendor file (38) 38
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (37) 37
Collection Dvlpm't (Acquisitions) - Closed Orders (28) 28
UofT at Mississauga - Stacks (8) 8
Gerstein Science - Periodical Stacks (7) 7
Chemistry (A D Allen) - Stacks (5) 5
Lakeridge Health Sciences - Online (4) 4
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Bindery (2) 2
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Reference (2) 2
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
East Asian (Cheng Yu Tung) - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (230786) 230786
Japanese (4501) 4501
German (3687) 3687
French (3579) 3579
Russian (1761) 1761
Chinese (1566) 1566
Italian (1128) 1128
Spanish (1000) 1000
Polish (542) 542
Hungarian (335) 335
Czech (314) 314
Dutch (266) 266
Danish (195) 195
Swedish (123) 123
Norwegian (119) 119
Portuguese (105) 105
Hebrew (86) 86
Finnish (77) 77
Romanian (70) 70
Bulgarian (66) 66
Ukrainian (65) 65
Korean (62) 62
Serbian (61) 61
Croatian (48) 48
Slovak (40) 40
Lithuanian (18) 18
Turkish (6) 6
Bosnian (3) 3
Greek (2) 2
Icelandic (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The journal of antimicrobial chemotherapy, ISSN 0305-7453, 1975
Journal
Anti-cancer agents in medicinal chemistry, ISSN 1871-5206, 2006
Journal
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
RESISTANT | MEDICINE, GENERAL & INTERNAL | MODELS | ANTITUMOR-ACTIVITY | INHIBITOR ALECTINIB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Anti-cancer drugs, ISSN 0959-4973, 1990
Journal
Current cancer therapeutics, ISSN 1074-2816, 1994
Journal
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment (goserelin plus tamoxifen or anastrozole) in premenopausal women... 
RECEIVING ADJUVANT LETROZOLE | MULTIPLE-MYELOMA | OVARIAN ABLATION | BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | DELTA-T-CELLS | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
2011, 5th ed., ISBN 9781605474311, 836
"Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the... 
Antineoplastic Agents | drug therapy | therapeutic use | Biological Agents | Neoplasms | Chemotherapy | Antineoplastic agents | Biological response modifiers | Immunotherapy | Cancer
Book
The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 25, pp. 2385 - 2394
In a prospective, randomized, phase 3 trial of crizotinib as second-line therapy in patients who had disease progression while receiving a platinum-based... 
REARRANGEMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | ONCOLOGY | EML4-ALK FUSION GENE | CLINICAL-TRIALS | PHASE-III | LYMPHOMA | OPEN-LABEL | DOCETAXEL | EGFR | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Glutamates - adverse effects | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Young Adult | Taxoids - therapeutic use | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Guanine - therapeutic use | Taxoids - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Intravenous administration | Biomedical research | Lung | Lung cancer | Liver | Fatigue | Chromosome rearrangements | Cancer therapies | Patients | Lymphoma | Metastases | Ovarian cancer | Quality of life | Confidence intervals | Chemotherapy | Dyspnea | Alopecia | Platinum | Lymphomas | Respiration | Pharmaceutical industry | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article